Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prostaglandin EP4 antagonist

Prostaglandin EP4 antagonist

US Patent 7273883 · Granted Sep 25, 2007

Estimated economic value: $45,929,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods of use for treating aberrant inflammation in peri-ocula2025
Use of prostacyclin antagonists for treating ocular surface nociception2024
Compositions and methods of use for treating aberrant inflammation in peri-ocula2023
Compounds and methods for the treatment of ocular disorders2023
Formulations for hair growth2022
Compounds and methods for the treatment of ocular disorders2022
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof2021
Compounds acting at multiple prostaglandin receptors giving a general anti-infla2021
Compounds and methods for the treatment of ocular disorders2020
Pharmaceutical compositions comprising an integrin alpha4 antagonist for use in 2020
Prostamide-containing intraocular implant2020
Prostamide-containing intraocular implant2020